UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4111-4116

2012

Volltextzugriff (PDF)

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BMC cancer, 2022-09, Vol.22 (1), p.971-9, Article 971

2022

Volltextzugriff (PDF)

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-09, Vol.12 (1), p.15805-10, Article 15805

2022

Volltextzugriff (PDF)

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-12, Vol.12 (1), p.21009-21009, Article 21009

2022

Volltextzugriff (PDF)

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2211-2217

2012

Volltextzugriff (PDF)

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma

AIDS (London), 2010-03, Vol.24 (6), p.851-856

2010

Volltextzugriff (PDF)

Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4696-4701

2011

Volltextzugriff (PDF)

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2192-2198

2009

Volltextzugriff (PDF)

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Journal of clinical oncology, 2019-03, Vol.37 (8), p.677-687

2019

Volltextzugriff (PDF)

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Journal of clinical oncology, 2023-12, Vol.41 (35), p.5376-5387

2023

Volltextzugriff (PDF)

CNS prophylaxis for diffuse large B-cell lymphoma

The lancet oncology, 2022-09, Vol.23 (9), p.e416-e426

2022

Volltextzugriff (PDF)

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Nature genetics, 2022-11, Vol.54 (11), p.1675-1689

2022

Volltextzugriff (PDF)

Burkitt Lymphoma International Prognostic Index

Journal of clinical oncology, 2021-04, Vol.39 (10), p.1129-1138

2021

Volltextzugriff (PDF)

Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant

Transplantation, 2020-12, Vol.104 (12), p.2582-2590

2020

Volltextzugriff (PDF)

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era

AIDS (London), 2014-03, Vol.28 (5), p.689-697

2014

Volltextzugriff (PDF)

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Journal of clinical oncology, 2024-08

2024

Volltextzugriff (PDF)

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

AIDS (London), 2015-05, Vol.29 (8), p.903-910

2015

Volltextzugriff (PDF)

Haemophagocytic syndrome and HIV

Current opinion in infectious diseases, 2009-02, Vol.22 (1), p.1-6

2009

Volltextzugriff (PDF)

Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report

Journal of medical case reports, 2010-01, Vol.4 (1), p.32-32, Article 32

2010

Volltextzugriff (PDF)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Journal of personalized medicine, 2023-07, Vol.13 (7), p.1182

2023

Volltextzugriff (PDF)

Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection

AIDS (London), 2012-04, Vol.26 (7), p.861-865

2012

Volltextzugriff (PDF)

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

Journal of personalized medicine, 2021-08, Vol.11 (9), p.876

2021

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

KollektionIngenta E-Journals

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(21)
Middle Aged
(13)
Adult
(11)
Male
(11)
Oncology
(11)
Female
(10)
Retrospective Studies
(10)
Aged
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Infectious Diseases
(8)
Biological And Medical Sciences
(7)
Immunology
(7)
Medical Sciences
(7)
Treatment Outcome
(6)
Young Adult
(6)
Aids/hiv
(5)
Antiretroviral Therapy, Highly Active
(5)
Chemotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma

Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial

Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study

CNS prophylaxis for diffuse large B-cell lymphoma

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Burkitt Lymphoma International Prognostic Index

Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Haemophagocytic syndrome and HIV

Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

Aktive Filter

Suchergebnisse filtern